Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Hunting For A Botulism Antidote

Chemical screening and animal trials suggest leads for treating the deadly disease

by Sophie L. Rovner
February 8, 2007

FIGHTING BACK
[+]Enlarge
2,4-Dichlorocinnamic hydroxamic acid (top) and a still-unnamed compound (bottom) could serve as the basis for treatments for botulism.
2,4-Dichlorocinnamic hydroxamic acid (top) and a still-unnamed compound (bottom) could serve as the basis for treatments for botulism.

Two compounds have been identified that could lead to potential drugs to combat botulin poisoning, which currently has few effective remedies (Proc. Natl. Acad. Sci. USA, DOI: 10.1073/pnas.0611213104).

The bacterial botulinum neurotoxin (BoNT) is a protein that can cause paralysis and death in microgram quantities. It's of particular interest because it "easily could be used in a bioterrorist attack," note Kim D. Janda of Scripps Research Institute and his colleagues.

The researchers screened a library of compounds for small molecules that disrupt the interaction between BoNT and the neural proteins it cleaves. Using kinetic analysis, cellular assays, and mouse trials, the team identified 2,4-dichlorocinnamic hydroxamic acid and a still-unnamed compound as leads for further optimization.

The researchers were frustrated because there was no correlation between the results of their cellular assays and animal studies. As such, they recommend development of in vitro cellular systems that more accurately predict the performance of antidotes in live animals.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.